IRIS
BARILLARI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.579
EU - Europa 1.946
AS - Asia 1.371
SA - Sud America 93
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 30.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.565
SG - Singapore 821
DE - Germania 439
UA - Ucraina 391
CN - Cina 300
IE - Irlanda 285
IT - Italia 270
RU - Federazione Russa 139
HK - Hong Kong 126
FR - Francia 91
GB - Regno Unito 89
PL - Polonia 89
BR - Brasile 80
SE - Svezia 40
FI - Finlandia 35
KR - Corea 33
ID - Indonesia 23
NL - Olanda 22
TW - Taiwan 19
AT - Austria 14
JP - Giappone 14
BE - Belgio 12
CA - Canada 9
ES - Italia 9
TR - Turchia 8
AR - Argentina 6
PH - Filippine 6
CZ - Repubblica Ceca 5
AL - Albania 4
DK - Danimarca 4
ZA - Sudafrica 4
BD - Bangladesh 3
EU - Europa 3
IN - India 3
MX - Messico 3
TH - Thailandia 3
AU - Australia 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
LV - Lettonia 2
MA - Marocco 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
RO - Romania 1
TN - Tunisia 1
VE - Venezuela 1
Totale 30.005
Salva come PNG Salva come JPEG
Città #
Wilmington 7.693
Woodbridge 7.441
Houston 6.803
Fairfield 619
Singapore 581
Chandler 577
Ann Arbor 391
Dearborn 318
Ashburn 280
Dublin 265
Seattle 224
Cambridge 210
Jacksonville 207
Medford 199
New York 153
Santa Clara 131
Hong Kong 121
Rome 116
Beijing 106
Lawrence 93
Kraków 88
Menlo Park 70
Zhengzhou 67
San Diego 50
Council Bluffs 46
Boardman 26
Milan 23
Nuremberg 22
Jakarta 21
Mülheim 19
Redwood City 17
Nanjing 16
Norwalk 15
The Dalles 14
Guangzhou 13
Verona 13
Brussels 12
Moscow 12
Mountain View 12
Los Angeles 11
Phoenix 10
Shanghai 10
Center 9
Frankfurt am Main 8
Kaohsiung 8
London 8
São Paulo 8
Chicago 7
University Park 7
Frankfurt Am Main 6
Hefei 6
Helsinki 6
Manila 6
Mcallen 6
San Francisco 6
San Mateo 6
Toronto 6
Wuhan 6
Ayn 5
Kunming 5
Philadelphia 5
Redmond 5
Salt Lake City 5
Vienna 5
Colorado Springs 4
Engelhard 4
Foggia 4
Halle 4
Indiana 4
Kissimmee 4
Lappeenranta 4
Palo Alto 4
Seoul 4
Shenzhen 4
Tampa 4
Amsterdam 3
Bangkok 3
Baotou 3
Cedarhurst 3
Hounslow 3
Iconha 3
Istanbul 3
Magenta 3
Olomouc 3
Osaka 3
Piracicaba 3
Prescot 3
Sacramento 3
Shenyang 3
Tirana 3
Washington 3
Arona 2
Beachwood 2
Belo Horizonte 2
Buffalo 2
Cairo 2
Cartoceto 2
Cesano Maderno 2
Chengdu 2
Coccaglio 2
Totale 27.364
Salva come PNG Salva come JPEG
Nome #
Detection of high nerve growth factor serum levels in AIDS-related and -unrelated Kaposi's sarcoma patients 485
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 461
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia 454
Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. 439
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis 429
HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway 418
Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses 418
Human T-lymphotropic retrovirus infection in Italy 416
Fibroblast growth factor-2 and the HIV-1 Tat protein synergize in promoting Bcl-2 expression and preventing endothelial cell apoptosis: implications for the pathogenesis of AIDS-associated Kaposi’s sarcoma. 414
The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells 413
The fibroblast growth factors. 405
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells 404
Pharmacological management of Kaposi’s sarcoma. 403
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis 402
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles 400
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 398
Spindle cells from Acquired Immune Deficiency Syndrome-associated Kaposi’s sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2. 393
Antitumor effects of antiretroviral therapy 384
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 379
Entrance of the tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels 378
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis. 373
Pathogenesis of AIDS-associated Kaposi's sarcoma 372
A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo 370
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS 370
HIV protease inhibitors as new treatment options for Kaposi's sarcoma 368
Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16ink4a. 366
HTLV-I and HIV infection in drug addicts in Italy 364
Treatment of Kaposi's sarcoma--an update 364
Angiogenic properties of human immunodeficiency virus type 1 Tat protein 363
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via proteasome-independent block of angiogenesis and matrix metalloproteinases. 361
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma 360
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients 359
Another mechanism involved in AIDS-KS progression. 356
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth 354
null 345
Transcription of placenta growth factor type-2 correlates with intratumoral microvessel density in breast carcinomas. 344
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation 343
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence 343
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines 340
HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population 339
Human T-lymphotropic retroviruses: a new member of the family. 336
HIV protease inhibitors block angiogenesis and promote regression of Kaposi’s sarcoma in the nude mouse model. 334
Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir 330
Spindle cells from AIDS-associated Kaposi's sarcoma (KS) lesions express telomerase activity that is enhanced by KS progression factors. 327
Tat, the transactivator gene of HIV-1, activates the expression of tumor necrosis factor-beta. 327
The use of HAART for biological tumour therapy 325
Release and angiogenic properties of extracellular HIV-1 Tat protein. 319
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles. 317
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor 317
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects (TAT domains and pathways for cell growth and transactivation activity). 316
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma 314
Immune activation, rather than immune deficiency, cooperates with HIV infection in the development of AIDS-associated Kaposi’s sarcoma. 314
Basic fibroblast growth factor mediates the growth and angiogenic activity of AIDS-Kaposi’s sarcoma (KS)-derived spindle cells and synergises with HIV-1 Tat protein in inducing KS-like lesions in mice. 313
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma 311
IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis 309
Basic fibroblast growth factor modifies the interactions between endothelial cells/fibronectin: Implications for progression of AIDS- associated Kaposi's sarcoma 303
Lymphokines released by activated or HTLV-infected T cells induce growth of normal mesenchymal cells and of cells derived from Kaposi’s sarcoma lesions of AIDS patients. 303
Tissue CEA as prognostic indicator in a series of 31 cases of gastric cancer 301
Interactions between endothelial cells and HIV-1 300
HIV-1 Tat protein mimics the effect of extracellular matrix (ECM) protein on vascular cell growth and angiogenesis: implications for AIDS-Kaposi’s sarcoma (AIDS-KS) pathogenesis. 300
The formation of new blood vessels in Kaposi’s sarcoma. 299
Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 298
Biological properties of Human Immunodeficiency Virus type-1 Tat protein: angiogenic effects and adhesive interactions of extracellular Tat. 296
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin 296
Integrin-mediated uptake of HIV-1 Tat protein by cytokine-activated endothelial cells. 292
PDGF-B as a possible growth factor in AIDS-KS. 292
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma 292
HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity 291
Mechanism of paclitaxel activity in Kaposi's sarcoma 290
Biology of Kaposi's sarcoma 286
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines 285
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis 283
[Chronic T-lymphocyte lymphatic leukemia. Clinico-pathologic assessment and new epidemiologic data related to cases correlated with HTLV-I in Italy] 283
Multicistronic antiangiogenic retroviral vectors for the gene therapy of malignant brain tumors. 276
The angiogenic properties of HIV-I Tat protein are mediated by two different domains. 275
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern Europe 275
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects. 272
Role of cytokines from activated T cells and HIV-1 Tat protein in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 272
HIV-1 Tat protein enhances angiogenesis and Kaposi’s sarcoma development triggered by inflammatory cytokines or bFGF by engaging the avb3 integrin. 267
Cytokines released by activated primary T cells stimulate the growth of AIDS-KS-derived cells and other cells of mesenchymal derivation. 267
The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor 265
Basic FGF induces lesions in mice resembling KS, and antisense oligonucleotides against this cytokine inhibit the growth and angiogenic activity of KS spindle cells. 265
Immune stimulation and HIV-1 infection have complementary effects in the induction and progression of AIDS-associated Kaposi’s sarcoma via release of cytokines and Tat. 258
Cooperation of HIV-1 Tat protein, inflammatory cytokines or bFGF in the pathogenesis of AIDS-Kaposis’s sarcoma. 253
[HIV protease inhibitors for the treatment of Kaposi's sarcoma] 253
Inflammatory cytokines increase mesenchymal cell growth and attachment induced by HIV-1 Tat protein and adhesion molecules: implications for AIDS-Kaposi’s sarcoma pathogenesis. 244
Activated peripheral blood lymphocytes produce factors promoting the growth of spindle cells derived from AIDS-associated Kaposi’s sarcoma. 213
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells 79
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 77
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 70
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo 67
The Anti-angiogenic effects of anti-human immunodeficiency virus drugs 58
HIV-1 tat protein enters dysfunctional endothelial cells via integrins and renders them permissive to virus replication 55
Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness 53
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview 51
The impact of human papilloma viruses, matrix metallo-proteinases and HIV protease inhibitors on the onset and progression of uterine cervix epithelial tumors: A review of preclinical and clinical studies 51
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 47
Radioresistance in rhabdomyosarcomas: much more than a question of dose 45
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 45
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 43
Totale 29.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.673 0 0 0 0 0 0 0 0 0 704 509 460
2020/20214.351 485 462 553 554 461 569 520 339 108 73 200 27
2021/2022919 19 130 13 63 18 43 48 119 32 54 85 295
2022/20231.326 159 110 100 143 97 276 113 80 123 43 68 14
2023/2024458 49 13 23 17 38 159 20 12 10 38 17 62
2024/20252.019 91 675 324 136 52 143 136 126 225 111 0 0
Totale 30.360